Medios AG: Berenberg rewards the strong quarterly report with a price target increase to €27!
Reading Time: 2 minutes
The Medios AG (i.), a leading provider of specialty pharma in Europe, reported strong business development in the first nine months of the fiscal year 2025, according to the figures presented on November 11. Group revenue increased by 9.2% to €1.53 billion compared to the previous year. Notably, the adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA pre) rose significantly by 26.1% to €70.4 million. This disproportionate increase resulted in an improvement of the EBITDA pre margin by 0.6 percentage points to 4.6%,...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
